Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial

BACKGROUND: 2-Hydroxybenzylamine (2-HOBA) is a selective dicarbonyl electrophile scavenger being developed as a nutritional supplement to help protect against the development of conditions associated with dicarbonyl electrophile formation, such as the cognitive decline observed with Mild Cognitive I...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Pharmacol Toxicol
Autors principals: Pitchford, Lisa M., Driver, Patricia M., Fuller, John C., Akers, Wendell S., Abumrad, Naji N., Amarnath, Venkataraman, Milne, Ginger L., Chen, Sheau-Chiann, Ye, Fei, Roberts, L. Jackson, Shoemaker, M. Benjamin, Oates, John A., Rathmacher, John A., Boutaud, Olivier
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6945443/
https://ncbi.nlm.nih.gov/pubmed/31907026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-020-0382-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars